collaboration
EVerZom enters research and licensing agreement with GENFIT
November 13, 2025Research and Development EVerZom, Eviv, GENFIT, Liver Diseases, collaboration, licensing agreement
EVerZom, a French biotech company developing exosome-based therapies for regenerative medicine, has entered into a research and licensing agreement with …
Custom Pharmaceuticals launches new company for drug product development
November 12, 2025Business Services Centrix Pharma Solutions, Company Launch, Custom Pharmaceuticals, collaboration, drug development, university of sussex
Customs Pharmaceuticals, a full-service contract development and manufacturing organisation (CDMO), has launched Centrix Pharma Solutions, a new company targeting faster …
AAX Biotech announces collaboration for cardiovascular antibody therapy
May 8, 2025Research and Development AAX Biotech, Cardiology, antibody therapies, collaboration, research and development
Swedish biotech firm AAX Biotech has entered a new collaboration focused on the development of antibody-based therapies targeting cardiovascular disease. …
Eisai and EcoNaviSta enter dementia collaboration
July 25, 2024Business Services EcoNaviSta, Eisai, Neurology, collaboration, dementia
Eisai and EcoNaviSta have announced that they have entered into a business alliance agreement, initiating their collaboration intended to build …
GSK and CureVac to restructure collaboration into licensing agreement
July 3, 2024Sales and Marketing CureVac, GSK, Immunology, License Agreement, collaboration
GSK and CureVac have announced that they have restructured their existing collaboration into a license agreement, which is intended to …
Sanofi, Formation Bio and OpenAI enter AI collaboration
May 22, 2024Research and Development Formation Bio, OpenAI, Pharmacy, Sanofi, collaboration
Sanofi, Formation Bio and OpenAI have announced that they have entered into a collaboration with the aim of building AI-powered …
AstraZeneca adds new heart failure target through collaboration with BenevolentAI
May 15, 2024Research and Development AstraZeneca, BenevolentAI, Cardiology, collaboration, heart failure
BenevolentAI has announced that AstraZeneca has added a novel heart failure target to its discovery portfolio following the two companies’ …
Fulcrum Therapeutics and Sanofi enter collaboration for facioscapulohumeral muscular dystrophy treatment
May 14, 2024Research and Development Musculo-skeletal disorder, Sanofi, collaboration, fulcrum therapeutics, muscular dystrophy
Fulcrum Therapeutics has announced that it has entered into a collaboration and license agreement with Sanofi for the development and …
Gossamer Bio and Chiesi Group enter into international collaboration to commercialise Seralutinib
May 7, 2024Research and Development Chiesi, Chronic Diseases, Gossamer Bio, PAH, PH-ILD, collaboration
US-based clinical stage biopharma company Gossamer Bio and Italian research-focused biopharma group Chiesi Farmaceutici have entered into an international agreement …
Beckman Coulter Life Sciences and Watchmaker Genomics enter collaboration
May 1, 2024Manufacturing and Production Beckman Coulter Life Sciences, DNA, Pharmacy, RNA, Watchmaker Genomics, collaboration
Beckman Coulter Life Sciences and Watchmaker Genomics have announced that they have entered into a collaborative partnership with the aim …
PeptiDream and Novartis extend peptide discovery collaboration
April 30, 2024Research and Development Novartis, PeptiDream, Pharmacy, collaboration, drug discovery, peptides
PeptiDream has announced the expansion of its peptide discovery collaboration with Novartis Pharma AG.
Medincell and AbbVie enter agreement for development of next-generation injectables
April 17, 2024Research and Development AbbVie, Immunology, Medincell, collaboration
Medincell and AbbVie have announced that they have entered into a collaboration to co-develop and commercialise up to six next-generation …
AbbVie and Tentarix collaborate on oncology and immunology treatments
February 23, 2024Research and Development AbbVie, Oncology, collaboration, immunology
AbbVie and Tentarix Biotherapeutics have announced that they have entered a multi-year collaboration focused on the discovery and development of …
Astellas and Kelonia Therapeutics enter agreement for development of immuno-oncology therapeutics
February 16, 2024Research and Development Astellas Pharma, Kelonia Therapeutics, Oncology, collaboration, immuno-oncology
Astellas Pharma and Kelonia Therapeutics have announced that Xyphos Biosciences (a wholly owned subsidiary of Astellas) and Kelonia have entered …
DelSiTech and Tolmar announce global license and development agreement
February 13, 2024Medical Communications DelSiTech, Pharmacy, Tolmar, collaboration
DelSiTech and Tolmar International have announced that they have entered into a global license and development agreement, following a previous …
Latest content
Five Facts about cardiovascular disease
